SCHEMBL2198441

SCHEMBL2198441

Cc1cc(OCCOC2CCCCO2)ccc1C(=O)c1ccc(Nc2ccc(Br)cc2NC(=O)CCC(=O)O)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.40
MAPK13 O15264 8/20 0.40
MAPK12 P53778 8/20 0.40
MAPK11 Q15759 8/20 0.40
MAPK14 Q16539 8/20 0.40
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CREBBP Q92793 1/20 0.33
NPC1 O15118 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
P2RX3 P56373 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HTT P42858 1/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198346 0.89 MAPK13 (0.45) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL2199324 0.88 MAPK13 (0.49) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL2196282 0.88 MAPK13 (0.40) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL2197456 0.87 MAPK13 (0.41) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL12424062 0.87 MAPK13 (0.56) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL12424162 0.84 MAPK13 (0.46) MAPK1MAPK13MAPK12MAPK11MAPK14
SCHEMBL2198313 0.84 MAPK13 (0.38) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL6817365 0.83 MAPK1 (0.49) MAPK1MAPK13MAPK12MAPK11MAPK14
SCHEMBL6817360 0.83 MAPK1 (0.49) MAPK1MAPK13MAPK12MAPK11MAPK14
SCHEMBL2200151 0.83 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK1 523/4885MAPK13 1063/4885MAPK12 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.